Floatz logo

Treximet®

Headache

Danish Headache CenterPhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Headache cohort.

Asset / SponsorPhaseRating
Topamax
University of Minnesota
Phase 4BBB
LIDOCAINE
Daniel A Tonetti, MD
Phase 4BBB
Prochlorperazine
Wake Forest University Health Sciences
Phase 4BBB
PROPOFOL
Medical College of Wisconsin
Phase 4BBB
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
HCA Florida North Florida Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Treximet® is also rated in:

migraine disorderDormant
BBB
Indicative ·
79 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →
Post-Traumatic HeadacheDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →